Skip to main content

vanderbilt vision research center Archives

Calkins lands national award for research on blinding eye diseases

Sep. 8, 2022—Vanderbilt's David Calkins, PhD, has been selected by the Research to Prevent Blindness and Association of University Professors of Ophthalmology to receive the 2023 David F. Weeks Award for Outstanding Vision Research.

Read more


Calkins named Assistant VP for Research at VUMC

Dec. 10, 2020—David Calkins, PhD, director of the Vanderbilt Vision Research Center and vice chair and director for Research of the Department of Ophthalmology and Visual Sciences, has been appointed Assistant Vice President for Research at Vanderbilt University Medical Center.

Read more


Study points to potential new approach to treating neurodegenerative diseases like glaucoma and Alzheimer’s disease

Jul. 20, 2020—Researchers at Vanderbilt University Medical Center have shown for the first time that when one optic nerve in the eye is damaged, as in glaucoma, the opposite optic nerve comes to the rescue by sharing its metabolic energy.

Read more


Glaucoma study finds brain fights to preserve vision

Feb. 22, 2018—A team of researchers, led by David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve vision.

Read more


Vision conference brings together research groups from across the Southeast

Oct. 5, 2017—The Vanderbilt Eye Institute (VEI) recently hosted the Southeastern Vision Conference to celebrate and share excellence in vision science.

Read more


Cytokine linked to blindness

Jun. 30, 2017—A signaling molecule called interleukin-6 may be a therapeutic target to prevent vision loss or nerve degeneration in glaucoma, Vanderbilt researchers have discovered.

Read more


Event celebrates scope of vision science at VUMC

Dec. 3, 2015—Vision science at Vanderbilt has experienced tremendous growth in recent years.

Read more


Clues to retinal cell degeneration

Aug. 28, 2012—A reversible chemical modification of rhodopsin, a receptor for light, plays a role in the degeneration of retinal cells.

Read more


Minds wide open: Neuroscience at Vanderbilt

Apr. 6, 2012—Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more